Glycoconjugate Journal

, Volume 20, Issue 4, pp 247–255 | Cite as

Galectin-4 in normal tissues and cancer

  • Margaret E. HuflejtEmail author
  • Hakon Leffler


Galectin-4 belongs to a subfamily of galectins composed of two carbohydrate recognition domains within the same peptide chain. The two domains have all the conserved galectin signature amino acids, but their overall sequences are only approximately 40% identical. Both domains bind lactose with a similar affinity as other galectins, but their respective preferences for other disaccharides, and larger saccharides, are distinctly different. Thus galectin-4 has a property of a natural cross-linker, but in a modified sense since each domain prefers a different subset of ligands. Similarly to other galectins, galectin-4 is synthesized as a cytosolic protein, but can be externalized. During development and in adult normal tissues, galectin-4 is expressed only in the alimentary tract, from the tongue to the large intestine. It is often found in relatively insoluble complexes, as a component of either adherens junctions or lipid rafts in the microvillus membrane, and it has been proposed to stabilize these structures. Strong expression of galectin-4 can be induced, however, in cancers from other tissues including breast and liver. Within a collection of human epithelial cancer cell lines, galectin-4 is overexpressed and soluble in those forming highly differentiated polarized monolayers, but absent in less differentiated ones. In cultured cells, intracellular galectin-4 may promote resistance to nutrient starvation, whereas—as an extracellular protein—it can mediate cell adhesion. Because of its distinct induction in breast and other cancers, it may be a valuable diagnostic marker and target for the development of inhibitory carbohydrate-based drugs. Published in 2004.

galectin-4 galectins carbohydrate specificity promoter breast cancer epithelial cells 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barondes SH, Cooper DN, Gitt MA, Leffler H, Galectins, Structure and function of a large family of animal lectins, J Biol Chem 269, 20807-10 (1994).PubMedGoogle Scholar
  2. 2.
    Cooper DN, Galectinomics: Finding themes in complexity, Biochim Biophys Acta 1572, 209-31 (2002).PubMedGoogle Scholar
  3. 3.
    Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F, Introduction to galectins, Glycoconjugate Journal 19, 433-40 (2004).PubMedCrossRefGoogle Scholar
  4. 4.
    Hirabayashi J, Satoh M, Kasai K, Evidence that Caenorhabditis elegans 32-kDa beta-galactoside-binding protein is homologous to vertebrate beta-galactoside-binding lectins, cDNA cloning and deduced amino acid sequence, J Biol Chem 267, 15485-90 (1992).PubMedGoogle Scholar
  5. 5.
    Shoji H, Nishi N, Hirashima M, Nakamura T, Characterization of the Xenopus galectin family, Three structurally different types as in mammals and regulated expression during embryogenesis, J Biol Chem 278, 12285-93 (2003).PubMedCrossRefGoogle Scholar
  6. 6.
    Houzelstein D, Goncalves I, Sidhu SS, Drickamer K, Cooper D, Leffler H, Poirier F, Phylogenetic analysis of the galectin family, Molecular Biology and Evolution in press (2004).Google Scholar
  7. 7.
    Oda Y, Herrmann J, Gitt MA, Turck CW, Burlingame AL, Barondes SH, Leffler H, Soluble lactose-binding lectin from rat intestine with two different carbohydrate-binding domains in the same peptide chain, J Biol Chem 268, 5929-39 (1993).PubMedGoogle Scholar
  8. 8.
    Huflejt ME, Jordan ET, Gitt MA, Barondes SH, Leffler H, Strikingly different localization of galectin-3 and galectin-4 in human colon adenocarcinoma T84 cells, Galectin-4 is localized at sites of cell adhesion, J Biol Chem 272, 14294-303 (1997).PubMedCrossRefGoogle Scholar
  9. 9.
    Bidon-Wagner N, Le Pennec J-P, Human Galectin-8 isoforms and cancer, Glycoconjugate Journal 19, 557-63 (2004).PubMedCrossRefGoogle Scholar
  10. 10.
    Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi T-a, Kageshita T, Saita N, Nakamura T, Galectin-9 in physiological and pathological conditions, Glycoconjugate Journal 19, 593-600 (2004).PubMedCrossRefGoogle Scholar
  11. 11.
    Leffler H, Masiarz FR, Barondes SH, Soluble lactose-binding vertebrate lectins:Agrowing family, Biochemistry 28, 9222-9 (1989).PubMedCrossRefGoogle Scholar
  12. 12.
    Tardy F, Deviller P, Louisot P, Martin A, Purification and characterization of the N-terminal domain of galectin-4 from rat small intestine, FEBS Lett 359, 169-72 (1995).PubMedCrossRefGoogle Scholar
  13. 13.
    Chiu ML, Jones JC, O'Keefe EJ, Restricted tissue distribution of a 37-kD possible adherens junction protein, J Cell Biol 119, 1689-700 (1992).PubMedCrossRefGoogle Scholar
  14. 14.
    Chiu ML, Parry DA, Feldman SR, Klapper DG, O'Keefe EJ, An adherens junction protein is a member of the family of lactosebinding lectins, J Biol Chem 269, 31770-6 (1994).PubMedGoogle Scholar
  15. 15.
    Danielsen EM, van Deurs B, Galectin-4 and small intestinal brush border enzymes form clusters, Mol Biol Cell 8, 2241-51 (1997).PubMedGoogle Scholar
  16. 16.
    Wasano K, Hirakawa Y, Rat intestinal galactoside-binding lectin L-36 functions as a structural protein in the superficial squamous cells of the esophageal epithelium, Cell Tissue Res 281, 77-83 (1995).PubMedGoogle Scholar
  17. 17.
    Braccia A, Villani M, Immerdal L, Niels-Christiansen LL, Nystrom BT, Hansen GH, Danielsen EM, Microvillar membrane microdomains exist at physiological temperature, Role of galectin-4 as lipid raft stabilizer revealed by “superrafts”, J Biol Chem 278, 15679-84 (2003).PubMedCrossRefGoogle Scholar
  18. 18.
    Rechreche H, Mallo GV, Montalto G, Dagorn JC, Iovanna JL, Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer, Eur J Biochem 248, 225-30 (1997).PubMedCrossRefGoogle Scholar
  19. 19.
    Jiang W, Puch S, Guo X, Bhavanandan VP, Signature sequences for the galectin-4 subfamily, IUBMB Life 48, 601-5 (1999).PubMedCrossRefGoogle Scholar
  20. 20.
    Gitt MA, Colnot C, Poirier F, Nani KJ, Barondes SH, Leffler H, Galectin-4 and galectin-6 are two closely related lectins expressed in mouse gastrointestinal tract, J Biol Chem 273, 2954-60 (1998).PubMedCrossRefGoogle Scholar
  21. 21.
    Poirier F, Roles of galectins in vivo, Biochem Soc Symp 95-103 (2002).Google Scholar
  22. 22.
    Wu AM, Wu JH, Tsai MS, Liu JH, Andre S, Wasano K, Kaltner H, Gabius HJ, Fine specificity of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N), Biochem J 367, 653-64 (2002).PubMedCrossRefGoogle Scholar
  23. 23.
    Wasano K, Hirakawa Y, Two domains of rat galectin-4 bind to distinct structures of the intercellular borders of colorectal epithelia, J Histochem Cytochem 47, 75-82 (1999).PubMedGoogle Scholar
  24. 24.
    Sórme P, Kahl-Knutsson B, Huflejt M, Nilsson UJ, Leffler H, Fluorescence polarization as an analytic tool to evaluate galectin-ligand interactions, Manuscript (submitted).Google Scholar
  25. 25.
    Ideo H, Seko A, Ohkura T, Matta KL, Yamashita K, High-affinity binding of recombinant human galectin-4 to SO(3)(-)?3Galbeta1?3GalNAc pyranoside, Glycobiology 12, 199-208 (2002).PubMedCrossRefGoogle Scholar
  26. 26.
    Kopitz J, Andre S, von Reitzenstein C, Versluis K, Kaltner H, Pieters RJ, Wasano K, Kuwabara I, Liu FT, Cantz M, Heck AJ, Gabius HJ, Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells, Oncogene 22, 6277-88 (2003).PubMedCrossRefGoogle Scholar
  27. 27.
    _Sólrme P, Kahl-Knutsson B, Huflejt M, Nilsson UJ, Leffler H, Common and selective high affinity inhibitors for galectins-1,-3 and-4, Manuscript (submitted).Google Scholar
  28. 29.
    Huflejt ME, Mossine VV, Naidenko O, Jazayeri M, Rogers P, Tinari N, Iacobelli SME, Lustgarten JMC, Synthetic lactulose amines bind tumor-promoting galectins-1 and-4, and inhibit breast cancers in Her-2/neu transgenic mice, 24th Annual San Antonio Breast Cancer Symposium abstract (2001).Google Scholar
  29. 30.
    Grassadonia A, Tinari N, Iurisci I, Piccolo E, Cumashi A, Innominato P, D'Egidio M, Natoli C, Piantelli M, Iacobelli S, 90 K (Mac-2 BP) and galectins in tumor progression and metastasis, Glycoconjugate Journal 19, 551-6 (2004).PubMedCrossRefGoogle Scholar
  30. 31.
    Takenaka Y, Fukumori T, R az A, galectin-3 and metastasis, Glycoconjugate Journal 19, 543-9 (2004).PubMedCrossRefGoogle Scholar
  31. 32.
    van den Brule F, Califice S, Castronovo V, Expression of galectins in cancer: A critical review, Glycoconjugate Journal 19, 537-42 (2004).PubMedCrossRefGoogle Scholar
  32. 33.
    Wollina U, Graefe T, Feldrappe S, Andre S, Wasano K, Kaltner H, Zick Y, Gabius HJ, Galectin fingerprinting by immuno-and lectin histochemistry in cutaneous lymphoma, J Cancer Res Clin Oncol 128, 103-10 (2002).PubMedCrossRefGoogle Scholar
  33. 34.
    Lahm H, Andre S, Hoeflich A, F ischer JR, Sordat B, Kaltner H, Wolf E, Gabius HJ, Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures, J Cancer Res Clin Oncol 127, 375-86 (2001).PubMedCrossRefGoogle Scholar
  34. 35.
    Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, Goseki N, Matsubara O, Takenaka K, Shichita M, Tanaka K, Shuda M, Yamamoto M, Identification and characterization of genes associated with human hepatocellular carcinogenesis, Cancer Res 59, 4990-6 (1999).PubMedGoogle Scholar
  35. 36.
    Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, Kodama T, Aburatani H, Differential gene expression pro-files of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes, Cancer Res 61, 889-95 (2001).PubMedGoogle Scholar
  36. 37.
    Huflejt ME, Geradts J, Elliott ML, Leffler H, Liu F-T, Galectin-4 is induced in human breast tumors and is localized to sites of cell adhesion in cultured cells, Eighty-Eighth Annual Meeting, American Association for Cancer Research, Proc Am Assoc Canc Res 38, 267 (1997).Google Scholar
  37. 38.
    Nagy N, Legendre H, Engels O, Andre S, Kaltner H, Wasano K, Zick Y, Pector JC, Decaestecker C, Gabius HJ, S almon I, Kiss R, Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting, Cancer 97, 1849- 58 (2003).PubMedCrossRefGoogle Scholar
  38. 39.
    Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ, Characterization of human colon cancer antigens recognized by autologous antibodies, Int J Cancer 76, 652-8 (1998).PubMedCrossRefGoogle Scholar
  39. 40.
    Tureci O, Schmitt H, Fadle N, Pfreundschuh M, Sahin U, Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease, J Biol Chem 272, 6416-22 (1997).PubMedCrossRefGoogle Scholar
  40. 41.
    Su ZZ, Lin J, Shen R, Fisher PE, Goldstein NI, Fisher PB, Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family, Proc Natl Acad Sci USA 93, 7252-7 (1996).PubMedCrossRefGoogle Scholar
  41. 42.
    Huflejt ME, Krtolica A, Ludlow JW, Leffler H, B arondes SH, Galectin-4 expression in human adenocarcinomas is correlated with a highly differentiated phenotype, Keystone Symposium on Molecular & Cellular Biology, Conference on Cancer Cell Invasion and Motility, J Cell Biochem 19B, 20 (1995).Google Scholar
  42. 43.
    Mehrabian M, Gitt MA, Sparkes RS, Leffler H, Barondes SH, Lusis AJ, Two members of the S-lac lectin gene family, LGALS1 and LGALS2, reside in close proximity on human chromosome 22q12-q13, Genomics 15, 418-20 (1993).PubMedCrossRefGoogle Scholar
  43. 44.
    Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K et al., Galectins: A family of animal beta-galactoside-binding lectins, Cell 76, 597-8 (1994).PubMedCrossRefGoogle Scholar
  44. 45.
    Gitt MA, Xia YR, Atchison RE, Lusis AJ, Barondes SH, Leffler H, Sequence, structure, and chromosomal mapping of the mouse Lgals6 gene, encoding galectin-6, J Biol Chem 273, 2961-70 (1998).PubMedCrossRefGoogle Scholar
  45. 46.
    Ponce AM, Analysis of Transcriptional Expression and Initiation of Galectin-4, a-galactoside Binding Lectin, M Sci Thesis; University of California, San Diego (1999).Google Scholar
  46. 47.
    Ponce AM, Huflejt ME, Transcriptional regulation of human galectin-4, Manuscript in Preparation.Google Scholar
  47. 48.
    Ye H, Kelly TF, Samadani U, Lim L, Rubio S, Overdier DG, Roebuck KA, Costa RH, Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues, Mol Cell Biol 17, 1626-41 (1997).PubMedGoogle Scholar
  48. 49.
    Ogura K, Choudhuri S, Klaassen CD, Full-length cDNA cloning and genomic organization of the mouse liver-specific organic anion transporter-1 (lst-1), Biochem Biophys Res Commun 272, 563-70 (2000).PubMedCrossRefGoogle Scholar
  49. 50.
    Jin L, Yang GY, Auborn K, Differences in C/EBPs in normal tissue and papillomas of the larynx, Cell Prolif 31, 127-38 (1998).PubMedCrossRefGoogle Scholar
  50. 51.
    Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL, Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein, Genes Dev 3, 1146-56 (1989).PubMedGoogle Scholar
  51. 52.
    Hurlin PJ, Foley KP, Ayer DE, Eisenman RN, Hanahan D, Arbeit JM, Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis, Oncogene 11, 2487-501 (1995).PubMedGoogle Scholar
  52. 53.
    Egan LJ, de Lecea A, Lehrman ED, Myhre GM, Eckmann L, Kagnoff MF, Nuclear factor-kappaB activation promotes restitution of wounded intestinal epithelial monolayers, Am J Physiol Cell Physiol 285, C1028-35 (2003).PubMedGoogle Scholar
  53. 54.
    Kagnoff MF, Eckmann L, Epithelial cells as sensors for microbial infection, J Clin Invest 100, 6-10 (1997).PubMedGoogle Scholar
  54. 55.
    Almkvist J, Karlsson A, Galectins as inflammatory mediators, Glycoconjugate Journal 19, 575-81 (2004).PubMedCrossRefGoogle Scholar
  55. 56.
    Sato S, Nieminen J, Seeing strangers or announcing “danger”: Galectin-3 in two models of innate immunity, Glycoconjugate Journal 19, 583-91 (2004).PubMedCrossRefGoogle Scholar
  56. 57.
    Mandrell RE, Apicella MA, Lindstedt R, Leffler H, Possible interaction between animal lectins and bacterial carbohydrates, Methods Enzymol 236, 231-54 (1994).PubMedGoogle Scholar
  57. 58.
    Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin Jr, AS, Selective activation of NF-kappa B subunits in human breast cancer: Potential roles for NF-kappa B2/p52 and for Bcl-3, Oncogene 19, 1123-31 (2000).PubMedCrossRefGoogle Scholar
  58. 59.
    Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr, RJ, Sledge Jr, GW, Constitutive activation of NF-B during progression of breast cancer to hormone-independent growth, Mol Cell Biol 17, 3629-39 (1997).PubMedGoogle Scholar
  59. 60.
    Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE, Aberrant nuclear factor-B/Rel expression and the pathogenesis of breast cancer, J Clin Investig 100, 2952-60 (1997).PubMedCrossRefGoogle Scholar
  60. 61.
    Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, Seldin DC, Cardiff RD, Sonenshein GE, Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors, Mol Cell Biol 23, 5738-54 (2003).PubMedCrossRefGoogle Scholar
  61. 62.
    Huflejt ME, Turck CW, Lindstedt R, Barondes SH, Leffler H, L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I, J Biol Chem 268, 26712-8 (1993).PubMedGoogle Scholar
  62. 63.
    Pienta KJ, Naik H, Akhtar A, Yamazaki K, Replogle TS, Lehr J, Donat TL, Tait L, Hogan V, Raz A, Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin, J Natl Cancer Inst 87, 348-53 (1995).PubMedGoogle Scholar
  63. 64.
    Glinsky GV, Price JE, Glinsky VV, Mossine VV, Kiriakova G, Metcalf JB, Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines, Cancer Res 56, 5319-24 (1996).PubMedGoogle Scholar
  64. 65.
    John CM, Leffler H, Kahl-Knutsson B, Svensson I, Jarvis GA, Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer, Clin Cancer Res 9, 2374-83 (2003).PubMedGoogle Scholar
  65. 67.
    Andre S, Pieters RJ, Vrasidas I, Kaltner H, Kuwabara I, Liu FT, Liskamp RM, Gabius HJ, Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates, Chembiochem 2, 822-30 (2001).PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  1. 1.Sidney Kimmel Cancer CenterSan DiegoUSA

Personalised recommendations